Genetic polymorphisms of myeloperoxidase and their effect on hypertension

Yi Chien Liu, Chi Jung Chung, Horng Sheng Shiue, Ya Yun Cheng, Shiau Rung Huang, Chien Tien Su, Yu Mei Hsueh

研究成果: 雜誌貢獻文章

8 引文 (Scopus)

摘要

Myeloperoxidase (MPO) is a member of the mammalian peroxidase superfamily and plays specific roles in host defense. This study aimed to explore the association between one polymorphism of MPO and hypertension risk. Study subjects were recruited from Taipei City Hospital, Zhongxiao Branch, Taipei Medical University Hospital and Taipei Municipal WanFang Hospital. Participants completed questionnaires and provided blood samples. In this study we considered hypertension to be present among subjects that had blood pressures above 140/90 mmHg, or who had previously received treatment for hypertension. The polymorphism of MPO investigated in this study was constructed by performing a restriction fragment length polymorphism following polymerase chain reaction. This study found the odds ratio and 95% confidence interval for hypertension among subjects with the MPO -463 GA/AA genotype to be 1.97 (1.23-3.16) when compared with those with the GG genotype after multivariate adjustment. Participants with a body mass index (BMI) ≥ 24 kg/m2 and with MPO -463 GA/AA genotype had a 4.60-fold increased risk of hypertension compared with those with a BMI <24 kg/m2 and with the GG genotype. This is the first study to conclude that the MPO -463 GA/AA genotype was associated with hypertension. In addition, we also detected that subjects with the MPO -463 GA/AA genotype that had higher BMIs and positive diabetes status tended to have higher risks of hypertension than subjects with the MPO -463 GA/AA genotype that had normal BMIs and were not diabetic.

原文英語
頁(從 - 到)282-289
頁數8
期刊Blood Pressure
22
發行號5
DOIs
出版狀態已發佈 - 十月 2013

指紋

Genetic Polymorphisms
Peroxidase
Hypertension
Genotype
Body Mass Index
Municipal Hospitals
Urban Hospitals
Restriction Fragment Length Polymorphisms
Odds Ratio
Confidence Intervals
Blood Pressure
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine

引用此文

Genetic polymorphisms of myeloperoxidase and their effect on hypertension. / Liu, Yi Chien; Chung, Chi Jung; Shiue, Horng Sheng; Cheng, Ya Yun; Huang, Shiau Rung; Su, Chien Tien; Hsueh, Yu Mei.

於: Blood Pressure, 卷 22, 編號 5, 10.2013, p. 282-289.

研究成果: 雜誌貢獻文章

Liu, Yi Chien ; Chung, Chi Jung ; Shiue, Horng Sheng ; Cheng, Ya Yun ; Huang, Shiau Rung ; Su, Chien Tien ; Hsueh, Yu Mei. / Genetic polymorphisms of myeloperoxidase and their effect on hypertension. 於: Blood Pressure. 2013 ; 卷 22, 編號 5. 頁 282-289.
@article{cd15a51fc71245cf8d0d1f735599a603,
title = "Genetic polymorphisms of myeloperoxidase and their effect on hypertension",
abstract = "Myeloperoxidase (MPO) is a member of the mammalian peroxidase superfamily and plays specific roles in host defense. This study aimed to explore the association between one polymorphism of MPO and hypertension risk. Study subjects were recruited from Taipei City Hospital, Zhongxiao Branch, Taipei Medical University Hospital and Taipei Municipal WanFang Hospital. Participants completed questionnaires and provided blood samples. In this study we considered hypertension to be present among subjects that had blood pressures above 140/90 mmHg, or who had previously received treatment for hypertension. The polymorphism of MPO investigated in this study was constructed by performing a restriction fragment length polymorphism following polymerase chain reaction. This study found the odds ratio and 95{\%} confidence interval for hypertension among subjects with the MPO -463 GA/AA genotype to be 1.97 (1.23-3.16) when compared with those with the GG genotype after multivariate adjustment. Participants with a body mass index (BMI) ≥ 24 kg/m2 and with MPO -463 GA/AA genotype had a 4.60-fold increased risk of hypertension compared with those with a BMI <24 kg/m2 and with the GG genotype. This is the first study to conclude that the MPO -463 GA/AA genotype was associated with hypertension. In addition, we also detected that subjects with the MPO -463 GA/AA genotype that had higher BMIs and positive diabetes status tended to have higher risks of hypertension than subjects with the MPO -463 GA/AA genotype that had normal BMIs and were not diabetic.",
keywords = "Hypertension, Myeloperoxidase, Polymorphism",
author = "Liu, {Yi Chien} and Chung, {Chi Jung} and Shiue, {Horng Sheng} and Cheng, {Ya Yun} and Huang, {Shiau Rung} and Su, {Chien Tien} and Hsueh, {Yu Mei}",
year = "2013",
month = "10",
doi = "10.3109/08037051.2012.759331",
language = "English",
volume = "22",
pages = "282--289",
journal = "Blood Pressure",
issn = "0803-7051",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Genetic polymorphisms of myeloperoxidase and their effect on hypertension

AU - Liu, Yi Chien

AU - Chung, Chi Jung

AU - Shiue, Horng Sheng

AU - Cheng, Ya Yun

AU - Huang, Shiau Rung

AU - Su, Chien Tien

AU - Hsueh, Yu Mei

PY - 2013/10

Y1 - 2013/10

N2 - Myeloperoxidase (MPO) is a member of the mammalian peroxidase superfamily and plays specific roles in host defense. This study aimed to explore the association between one polymorphism of MPO and hypertension risk. Study subjects were recruited from Taipei City Hospital, Zhongxiao Branch, Taipei Medical University Hospital and Taipei Municipal WanFang Hospital. Participants completed questionnaires and provided blood samples. In this study we considered hypertension to be present among subjects that had blood pressures above 140/90 mmHg, or who had previously received treatment for hypertension. The polymorphism of MPO investigated in this study was constructed by performing a restriction fragment length polymorphism following polymerase chain reaction. This study found the odds ratio and 95% confidence interval for hypertension among subjects with the MPO -463 GA/AA genotype to be 1.97 (1.23-3.16) when compared with those with the GG genotype after multivariate adjustment. Participants with a body mass index (BMI) ≥ 24 kg/m2 and with MPO -463 GA/AA genotype had a 4.60-fold increased risk of hypertension compared with those with a BMI <24 kg/m2 and with the GG genotype. This is the first study to conclude that the MPO -463 GA/AA genotype was associated with hypertension. In addition, we also detected that subjects with the MPO -463 GA/AA genotype that had higher BMIs and positive diabetes status tended to have higher risks of hypertension than subjects with the MPO -463 GA/AA genotype that had normal BMIs and were not diabetic.

AB - Myeloperoxidase (MPO) is a member of the mammalian peroxidase superfamily and plays specific roles in host defense. This study aimed to explore the association between one polymorphism of MPO and hypertension risk. Study subjects were recruited from Taipei City Hospital, Zhongxiao Branch, Taipei Medical University Hospital and Taipei Municipal WanFang Hospital. Participants completed questionnaires and provided blood samples. In this study we considered hypertension to be present among subjects that had blood pressures above 140/90 mmHg, or who had previously received treatment for hypertension. The polymorphism of MPO investigated in this study was constructed by performing a restriction fragment length polymorphism following polymerase chain reaction. This study found the odds ratio and 95% confidence interval for hypertension among subjects with the MPO -463 GA/AA genotype to be 1.97 (1.23-3.16) when compared with those with the GG genotype after multivariate adjustment. Participants with a body mass index (BMI) ≥ 24 kg/m2 and with MPO -463 GA/AA genotype had a 4.60-fold increased risk of hypertension compared with those with a BMI <24 kg/m2 and with the GG genotype. This is the first study to conclude that the MPO -463 GA/AA genotype was associated with hypertension. In addition, we also detected that subjects with the MPO -463 GA/AA genotype that had higher BMIs and positive diabetes status tended to have higher risks of hypertension than subjects with the MPO -463 GA/AA genotype that had normal BMIs and were not diabetic.

KW - Hypertension

KW - Myeloperoxidase

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=84884680701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884680701&partnerID=8YFLogxK

U2 - 10.3109/08037051.2012.759331

DO - 10.3109/08037051.2012.759331

M3 - Article

C2 - 23384293

AN - SCOPUS:84884680701

VL - 22

SP - 282

EP - 289

JO - Blood Pressure

JF - Blood Pressure

SN - 0803-7051

IS - 5

ER -